Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An insulin sensitizer is a type of molecule or drug that enhances the responsiveness of cells to insulin, thereby improving glucose uptake and utilization in tissues such as muscle, fat, and liver. This action helps lower blood sugar levels and is particularly relevant in the management of conditions characterized by insulin resistance, such as type 2 diabetes mellitus (T2DM) and polycystic ovary syndrome (PCOS).
Enhances the responsiveness of cells to insulin, improving glucose uptake and utilization in tissues.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin Sensitizer (None).